1. Home
  2. XERS vs AAOI Comparison

XERS vs AAOI Comparison

Compare XERS & AAOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • AAOI
  • Stock Information
  • Founded
  • XERS 2005
  • AAOI 1997
  • Country
  • XERS United States
  • AAOI United States
  • Employees
  • XERS N/A
  • AAOI N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • AAOI Semiconductors
  • Sector
  • XERS Health Care
  • AAOI Technology
  • Exchange
  • XERS Nasdaq
  • AAOI Nasdaq
  • Market Cap
  • XERS 628.7M
  • AAOI 707.6M
  • IPO Year
  • XERS 2018
  • AAOI 2013
  • Fundamental
  • Price
  • XERS $5.01
  • AAOI $14.67
  • Analyst Decision
  • XERS Strong Buy
  • AAOI Buy
  • Analyst Count
  • XERS 6
  • AAOI 4
  • Target Price
  • XERS $6.25
  • AAOI $25.50
  • AVG Volume (30 Days)
  • XERS 2.2M
  • AAOI 3.1M
  • Earning Date
  • XERS 05-08-2025
  • AAOI 05-08-2025
  • Dividend Yield
  • XERS N/A
  • AAOI N/A
  • EPS Growth
  • XERS N/A
  • AAOI N/A
  • EPS
  • XERS N/A
  • AAOI N/A
  • Revenue
  • XERS $222,551,000.00
  • AAOI $308,551,000.00
  • Revenue This Year
  • XERS $31.75
  • AAOI $113.56
  • Revenue Next Year
  • XERS $21.09
  • AAOI $64.07
  • P/E Ratio
  • XERS N/A
  • AAOI N/A
  • Revenue Growth
  • XERS 29.88
  • AAOI 50.30
  • 52 Week Low
  • XERS $1.72
  • AAOI $6.70
  • 52 Week High
  • XERS $6.07
  • AAOI $44.50
  • Technical
  • Relative Strength Index (RSI)
  • XERS 59.63
  • AAOI 53.00
  • Support Level
  • XERS $4.26
  • AAOI $13.31
  • Resistance Level
  • XERS $5.28
  • AAOI $15.40
  • Average True Range (ATR)
  • XERS 0.28
  • AAOI 1.15
  • MACD
  • XERS 0.09
  • AAOI 0.55
  • Stochastic Oscillator
  • XERS 78.91
  • AAOI 85.52

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About AAOI Applied Optoelectronics Inc.

Applied Optoelectronics Inc is a provider of fiber-optic networking products, for four networking end-markets; internet data center, CATV, telecom, and FTTH. The Company designs and manufactures a wide range of optical communications products at varying levels of integration, from components, subassemblies, and modules to complete turn-key equipment. Through direct sales personnel, and manufacturing teams in the United States, China, and Taiwan, the company coordinates with customers to determine product design, qualifications, and performance. The Company has manufacturing and research and development facilities located in the U.S., Taiwan, and China.

Share on Social Networks: